#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
APH_6__Id.3002660.AF024602.3155_3992.467	APH_6__Id.3002660.AF024602.3155_3992.467	1	0	16	8	APH_6__Id+	837	162	100.0	APH_6__Id+.l15.c4.ctg.1	162	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	APH(6)-Id;APH(6)-Id is an aminoglycoside phosphotransferase encoded by plasmids, integrative conjugative elements and chromosomal genomic islands in K. pneumoniae, Salmonella spp., E. coli, Shigella flexneri, Providencia alcalifaciens, Pseudomonas spp., V. cholerae, Edwardsiella tarda, Pasteurella multocida and Aeromonas bestiarum
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	788	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1374	43.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	467	469	ACG	76;75;79	A;C;G	75;74;77	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	38	Enterobacter_aerogenes_omp36	1128	101	94.06	Enterobacter_aerogenes_omp36.l15.c4.ctg.1	110	12.4	0	.	p	.	0	L329V	NONSYN	985	987	CTG	28	30	GTT	14;14;14	G;T;T	14;14;14	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	38	Enterobacter_aerogenes_omp36	1128	101	94.06	Enterobacter_aerogenes_omp36.l15.c4.ctg.1	110	12.4	0	.	p	.	0	K354Q	NONSYN	1060	1062	AAG	103	105	CAG	5;4;4	C;A;G	5;4;4	.	Enterobacter aerogenes omp36 mutants
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1576	82.1	1	SNP	p	R234F	1	.	.	700	702	TTC	1066	1068	TTC	127;120;125	T;T;C	126;119;124	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1576	82.1	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1366	1368	CGT	86;88;84	C,A;G;T	84,1;87;83	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1576	82.1	0	HET	.	.	.	T123A	.	123	123	T	489	489	T	75	T,A	55,19	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1576	82.1	0	HET	.	.	.	T126G	.	126	126	T	492	492	T	76	T,G	56,18	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1576	82.1	0	HET	.	.	.	C255T	.	255	255	C	621	621	C	139	C,T	78,61	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1576	82.1	0	HET	.	.	.	C144T	.	144	144	C	510	510	C	71	C,T	49,22	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	1210	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1576	82.1	0	HET	.	.	.	C114T	.	114	114	C	480	480	C	76	C,T	53,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	91	96.7	Escherichia_coli_EF_Tu.l15.c17.ctg.3	440	17.6	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	86	88	AGC	20;20;20	A;G;C	20;20;20	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	679	1976	Escherichia_coli_EF_Tu	1230	94	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.4	320	16.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	972	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	2088	35.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1728	1730	AAA	37;37;37	A;A;A	36;37;37	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1090	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l6.c30.ctg.1	1931	42.5	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1315	1317	GAA	68;67;67	G;A;A	68;67;66	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	532	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	1243	32.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1136G	SNP	1136	1136	A	95	95	G	175	G	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1138C	SNP	1138	1138	T	97	97	C	170	C	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1142C	SNP	1142	1142	T	101	101	C	175	C	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	C1170T	SNP	1170	1170	C	129	129	T	250	T	247	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1220C	SNP	1220	1220	T	179	179	C	250	C	250	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1245C	SNP	1245	1245	T	204	204	C	161	C	159	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	G1253A	SNP	1253	1253	G	212	212	A	163	A	162	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	G1256A	SNP	1256	1256	G	215	215	A	152	A	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	C1258A	SNP	1258	1258	C	217	217	A	129	A	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	G1266T	SNP	1266	1266	G	225	225	T	129	T	127	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1267C	SNP	1267	1267	T	226	226	C	129	C	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1275C	SNP	1275	1275	T	234	234	C	129	C	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	G1276A	SNP	1276	1276	G	235	235	A	129	A	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1281G	SNP	1281	1281	A	240	240	G	138	G	137	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1283C	SNP	1283	1283	T	242	242	C	145	C	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	G1288T	SNP	1288	1288	G	247	247	T	161	T	158	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1296G	SNP	1296	1296	A	255	255	G	197	G	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1299G	SNP	1299	1299	T	258	258	G	196	G	195	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1300T	SNP	1300	1300	A	259	259	T	197	T	196	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	C1356T	SNP	1356	1356	C	315	315	T	236	T	233	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1358G	SNP	1358	1358	A	317	317	G	230	G	230	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1368C	SNP	1368	1368	T	327	327	C	236	C	233	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	G1370A	SNP	1370	1370	G	329	329	A	238	A	235	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	C1406.	DEL	1406	1406	C	364	364	C	165	C	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	.1409C	INS	1409	1409	T	368	368	C	156	C	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	C1431A	SNP	1431	1431	C	390	390	A	140	A	137	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	C1432A	SNP	1432	1432	C	391	391	A	148	A,G	145,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1441G	SNP	1441	1441	A	400	400	G	113	G	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	T1464C	SNP	1464	1464	T	423	423	C	102	C	102	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	G1473T	SNP	1473	1473	G	432	432	T	122	T	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1475G	SNP	1475	1475	A	434	434	G	122	G,T	119,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	0	.	n	.	0	A1548T	SNP	1548	1548	A	507	507	T	136	T	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	3072	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.3	516	175.4	1	SNP	n	C1194G	0	.	.	1194	1194	C	153	153	C	252	C	251	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	800	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1631	36.7	0	.	p	.	0	H2R	NONSYN	4	6	CAT	283	285	CGT	33;35;35	C;G;T	33;35;35	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	800	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1631	36.7	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1126	1128	GGC	46;42;41	G;G;C	45;41;40	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1662	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2373	52.9	0	.	p	.	0	R8S	NONSYN	22	24	AGA	387	389	AGC	41;39;40	A;G;C	41;39;40	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1662	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2373	52.9	0	.	p	.	0	I142L	NONSYN	424	426	ATA	789	791	CTA	45;45;45	C;T;A	45;45;44	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1662	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2373	52.9	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1308	1310	CAA	80;79;80	C;A;A	80;79;80	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1662	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2373	52.9	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1407	1409	GGT	61;60;59	G;G;T	60;60;57	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1662	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	2373	52.9	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1977	1979	GTT	87;86;86	G;T;T	87;86;86	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1348	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1944	52.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	771	773	GAA	96;94;94	G;A;A	96;94;93	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1348	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1944	52.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	951	953	ACC	32;32;32	A;C;C	31;31;32	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1348	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1944	52.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	1071	1073	ACT	32;30;29	A;C;T	32;30;29	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1348	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1944	52.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1461	1463	ATC	30;30;30	A;T;C	29;29;30	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	874	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1595	40.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2196	acrD	3114	3114	99.1	acrD.l15.c17.ctg.1	3722	44.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	467	469	ATC	67;67;68	A;T;C	66;67;68	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2196	acrD	3114	3114	99.1	acrD.l15.c17.ctg.1	3722	44.4	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2180	2182	AAG	49;50;51	A;A;G	49;50;51	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1044	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1709	46.1	0	.	p	.	0	A22V	NONSYN	64	66	GCC	344	346	GTC	63;63;64	G;T;C	63;63;64	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1044	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1709	46.1	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1085	1087	TGC	53;52;50	T;G;C	53;51;50	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2588	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3708	52.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	461	461	T	37	T	37	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2588	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3708	52.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	767	769	GAC	69;67;68	G;A;C	68;66;68	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2588	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3708	52.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1043	1045	TTA	40;42;42	T;T;A	39;42;42	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2588	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3708	52.8	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2120	2122	AAT	64;63;63	A;A;T	63;63;63	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2588	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3708	52.8	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2234	2236	AGT	54;54;54	A;G;T	54;54;54	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2588	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3708	52.8	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2633	2635	GTG	54;53;53	G;T;G	54;52;53	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2588	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3708	52.8	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3188	3190	AAG	84;85;85	A;A;G	84;84;85	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	1024	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1412	55.0	1	SNP	p	R45C	0	.	.	133	135	CGC	541	543	CGC	102;103;100	C;G;C	102;102;100	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	992	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1326	56.5	0	.	p	.	0	L34F	NONSYN	100	102	CTC	403	405	TTC	49;49;51	T;T;C	47;48;51	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	992	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1326	56.5	0	.	p	.	0	E122G	NONSYN	364	366	GAG	667	669	GGG	98;96;95	G;G;G	98;96;95	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1246	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1366	68.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	655	657	CTT	140;138;138	C;T;T	139;138;138	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2060	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	3277	47.5	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2167	2169	GCA	77;78;79	G;C;A	77;78;79	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2060	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	3277	47.5	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2428	2430	ACC	54;54;55	A;C;C	50;53;54	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2060	alaS	2631	2631	98.94	alaS.l6.c30.ctg.1	3277	47.5	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2737	2739	GCC	57;54;55	G;C;C	57;53;55	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1454	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2435	43.4	0	.	p	.	0	G37A	NONSYN	109	111	GGT	510	512	GCT	22;22;22	G;C;T	22;22;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1454	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2435	43.4	0	.	p	.	0	D77E	NONSYN	229	231	GAT	630	632	GAG	25;27;29	G;A;G	23;25;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1454	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2435	43.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	666	668	TGC	39;38;39	T;G;C	39;36;38	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1454	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2435	43.4	0	.	p	.	0	I150V	NONSYN	448	450	ATT	849	851	GTT	21;21;21	G;T;T	21;21;21	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1454	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2435	43.4	0	.	p	.	0	R200H	NONSYN	598	600	CGC	999	1001	CAC	31;31;31	C;A;C	31;31;31	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1454	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2435	43.4	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1284	1286	ATG	40;40;39	A;T;G	40;40;38	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1454	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2435	43.4	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2280	2282	CGC	37;38;37	C;G;C	36;37;34	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	576	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1399	30.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	1041	1043	ACC	30;32;32	A;C;C	30;32;32	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	576	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1399	30.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1053	1055	TCG	39;39;40	T;C;G,A	38;39;39,1	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	498	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1499	25.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	860	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2013	32.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1441	1443	AAA	39;39;41	A;A;A	39;39;41	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	860	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2013	32.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1453	1455	GAG	34;34;34	G;A;G	33;33;34	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	860	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2013	32.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1459	1461	CAC	36;36;35	C;A;C	36;36;35	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	860	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2013	32.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1513	1515	GAG	28;26;26	G;A;G	28;25;26	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	784	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1872	31.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	624	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1340	34.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	974	cysB	975	975	99.38	cysB.l15.c17.ctg.1	1596	45.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	16	12	dfrA1_1	474	179	100.0	dfrA1_1.l15.c4.ctg.1	179	1.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	836	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1980	31.9	0	.	p	.	0	W42C	NONSYN	124	126	TGG	534	536	TGT	45;45;45	T;G;T	45;44;45	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	836	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1980	31.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	1065	1067	GTC	44;43;43	G;T;C	43;43;43	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1030	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	2150	36.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	782	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1855	31.8	0	.	p	.	0	G209S	NONSYN	625	627	GGC	921	923	AGC	41;41;39	A;G;C	41;40;39	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	146	emrE_1	333	224	91.07	emrE_1.l15.c30.ctg.1	442	6.7	0	.	p	.	0	I100V	NONSYN	298	300	ATT	189	191	GTC	11;11;11	G;T;C	11;11;11	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	146	emrE_1	333	224	91.07	emrE_1.l15.c30.ctg.1	442	6.7	0	.	p	.	0	T108A	NONSYN	322	324	ACA	213	215	GCA	12;12;12	G;C;A	12;12;12	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1428	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1878	57.5	0	.	p	.	0	K176R	NONSYN	526	528	AAG	902	904	AGG	40;40;35	A;G;G	40;39;33	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1428	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1878	57.5	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1292	1294	GAC	58;56;50	G;A;C	58;56;50	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	780	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1256	46.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	2318	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2259	77.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	1058	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1411	56.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	600	602	CTG	106;106;106	C;T;G	106;106;106	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	408	410	ATA	69;69;69	A;T;A	68;68;69	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	420	422	GTA	75;73;72	G;T,G;A	75;72,1;71	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	573	575	ACG	86;89;84	A;C;G	86;88;83	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	636	638	GAA	73;73;75	G;A;A	73;73;75	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	675	677	GCT	64;59;58	G;C;T	63;59;57	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	693	695	GAT	77;77;77	G;A;T	74;74;74	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	780	782	TCA	84;89;89	T;C;A	84;88;89	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	909	911	CAG	114;111;112	C;A;G	113;111;112	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1047	1049	GTT	121;115;114	G;T;T	121;115;114	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1203	1205	GAT	72;75;78	G;A;T	72;74;76	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1371	1373	AAT	68;69;67	A;A;T	67;69;66	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1392	1394	TTA	45;45;43	T;T;A	45;45;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1593	1595	AAA	48;47;47	A;A;A	48;47;47	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2328	2330	CAT	85;87;87	C;A;T	85;87;87	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2382	2384	CAT	93;94;96	C;A;T	92;94;96	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2400	2402	AGA	92;94;93	A;G;A	92;94;93	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2415	2417	AAT	77;77;77	A;A;T	76;77;76	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2562	2564	TCC	62;61;62	T;C;C	62;61;60	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2727	2729	ATT	77;77;77	A;T;T	77;75;77	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2748	2750	GAT	67;66;65	G;A;T	67;64;64	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2862	2864	GTT	120;119;120	G;T;T	120;118;120	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	4452	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4290	78.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3147	3149	CAC	69;66;67	C;A;C	69;65;67	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	864	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1396	46.4	1	SNP	p	P64R	0	.	.	190	192	CCA	528	530	CCA	68;67;67	C;C;A	67;67;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	864	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1396	46.4	1	SNP	p	P64H	0	.	.	190	192	CCA	528	530	CCA	68;67;67	C;C;A	67;67;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	864	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1396	46.4	1	SNP	p	P64L	0	.	.	190	192	CCA	528	530	CCA	68;67;67	C;C;A	67;67;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	864	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1396	46.4	1	SNP	p	P64S	0	.	.	190	192	CCA	528	530	CCA	68;67;67	C;C;A	67;67;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	864	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1396	46.4	1	SNP	p	P64A	0	.	.	190	192	CCA	528	530	CCA	68;67;67	C;C;A	67;67;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	1128	gadE	528	528	100.0	gadE.l15.c17.ctg.1	1204	70.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	A2T	NONSYN	4	6	GCT	15	17	ACT	2;2;2	A;C;T	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	V10I	NONSYN	28	30	GTT	39	41	ATT	3;3;3	A;T;T	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	H17Y	NONSYN	49	51	CAT	60	62	TAT	4;4;4	T;A;T	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	Q21H	NONSYN	61	63	CAA	72	74	CAT	4;4;4	C;A;T	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	L31V	NONSYN	91	93	CTG	102	104	GTG	7;7;7	G;T;G	7;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	D34E	NONSYN	100	102	GAT	111	113	GAG	7;6;6	G;A;G	7;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	L46P	NONSYN	136	138	CTG	147	149	CCG	5;5;5	C;C;G	5;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	E54D	NONSYN	160	162	GAA	171	173	GAT	4;4;4	G;A;T	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	I88M	NONSYN	262	264	ATA	273	275	ATG	7;7;7	A;T;G	6;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	276	278	CCG	7;7;7	C;C;G	7;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	D100E	NONSYN	298	300	GAC	309	311	GAA	11;11;11	G;A;A	11;11;11	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	P101S	NONSYN	301	303	CCC	312	314	TCC	11;11;11	T;C;C	11;11;11	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	R102G	NONSYN	304	306	CGG	315	317	GGG	10;10;10	G;G;G	10;10;10	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	K110N	NONSYN	328	330	AAA	339	341	AAT	15;17;17	A;A;T	14;17;17	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	274	gadW	729	729	94.24	gadW.l6.c4.ctg.1	967	21.2	0	.	p	.	0	S234A	NONSYN	700	702	TCG	711	713	GCG	17;18;18	G;C;G	17;18;18	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1004	gadX	825	825	97.82	gadX.l15.c30.ctg.1	1496	50.7	0	.	p	.	0	F53L	NONSYN	157	159	TTC	482	484	TTA	85;82;77	T;T;A	83;80;76	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1004	gadX	825	825	97.82	gadX.l15.c30.ctg.1	1496	50.7	0	.	p	.	0	V79I	NONSYN	235	237	GTT	560	562	ATT	84;84;87	A;T;T	84;84;87	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1004	gadX	825	825	97.82	gadX.l15.c30.ctg.1	1496	50.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1061	1063	GGA	34;32;31	G;G;A	34;32;30	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1004	gadX	825	825	97.82	gadX.l15.c30.ctg.1	1496	50.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1067	1069	CCG	31;30;29	C;C;G	31;30;29	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2355	2357	GAA	31;31;31	G;A;A	31;30;31	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	S83I	0	.	.	247	249	TCG	570	572	TCG	59;58;58	T;C,T;G	59;56,1;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	S83W	0	.	.	247	249	TCG	570	572	TCG	59;58;58	T;C,T;G	59;56,1;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	S83L	0	.	.	247	249	TCG	570	572	TCG	59;58;58	T;C,T;G	59;56,1;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	D87G	0	.	.	259	261	GAC	582	584	GAC	62;61;60	G;A;C	59;58;59	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	D87V	0	.	.	259	261	GAC	582	584	GAC	62;61;60	G;A;C	59;58;59	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	D87H	0	.	.	259	261	GAC	582	584	GAC	62;61;60	G;A;C	59;58;59	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	D87N	0	.	.	259	261	GAC	582	584	GAC	62;61;60	G;A;C	59;58;59	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1914	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3285	43.9	1	SNP	p	D87Y	0	.	.	259	261	GAC	582	584	GAC	62;61;60	G;A;C	59;58;59	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1584	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2990	39.9	1	SNP	p	R136I	0	.	.	406	408	CGC	681	683	CGC	45;45;46	C,T;G;C	41,1;45;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1584	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2990	39.9	1	SNP	p	R136E	0	.	.	406	408	CGC	681	683	CGC	45;45;46	C,T;G;C	41,1;45;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1584	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2990	39.9	1	SNP	p	R136C	0	.	.	406	408	CGC	681	683	CGC	45;45;46	C,T;G;C	41,1;45;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1584	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2990	39.9	1	SNP	p	R136H	0	.	.	406	408	CGC	681	683	CGC	45;45;46	C,T;G;C	41,1;45;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1584	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2990	39.9	1	SNP	p	R136S	0	.	.	406	408	CGC	681	683	CGC	45;45;46	C,T;G;C	41,1;45;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1584	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2990	39.9	1	SNP	p	R136L	0	.	.	406	408	CGC	681	683	CGC	45;45;46	C,T;G;C	41,1;45;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1584	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2990	39.9	1	SNP	p	R136G	0	.	.	406	408	CGC	681	683	CGC	45;45;46	C,T;G;C	41,1;45;45	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	448	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1431	23.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	616	618	CCG	32;30;31	C;C;G	30;30;30	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	448	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1431	23.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	769	771	GCC	22;21;21	G;C;C	19;21;19	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1216	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1656	55.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	329	331	TCA	44;43;44	T;C;A	43;43;44	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	478	marA	384	384	99.74	marA.l15.c30.ctg.1	1251	28.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	687	689	AGC	39;37;41	A;G;C	39;37;41	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	789	791	CAT	36;35;36	C;A;T	35;33;36	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	V45E	0	.	.	133	135	GTG	513	515	GTG	76;73;69	G;T;G,T	76;71;68,1	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	I49S	0	.	.	145	147	ATC	525	527	ATC	75;77;76	A;T;C	75;77;76	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	A70T	0	.	.	208	210	GCA	588	590	GCA	60;58;58	G;C;A	60;58;58	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	R73C	0	.	.	217	219	CGT	597	599	CGT	57;58;56	C;G;T	56;58;56	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	R73S	0	.	.	217	219	CGT	597	599	CGT	57;58;56	C;G;T	56;58;56	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	R77C	0	.	.	229	231	CGC	609	611	CGC	55;55;55	C;G;C	55;55;55	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	R77L	0	.	.	229	231	CGC	609	611	CGC	55;55;55	C;G;C	55;55;55	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	L78M	0	.	.	232	234	CTG	612	614	CTG	57;57;56	C;T;G	57;57;56	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	R94H	0	.	.	280	282	CGC	660	662	CGC	38;38;38	C;G;C	38;38;38	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	R94S	0	.	.	280	282	CGC	660	662	CGC	38;38;38	C;G;C	38;38;38	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	456	marR	435	435	97.7	marR.l6.c30.ctg.1	1031	33.0	1	SNP	p	V96E	0	.	.	286	288	GTA	666	668	GTA	40;39;39	G;T;A	40;39;39	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	S7F	NONSYN	19	21	TCC	307	309	TTC	35;35;35	T;T;C	34;35;35	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	R36I	NONSYN	106	108	AGG	394	396	ATC	23;22;22	A;T;C	23;22;22	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	E42A	NONSYN	124	126	GAA	412	414	GCC	25;26;26	G;C;C	25;26;26	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	N43V	NONSYN	127	129	AAT	415	417	GTG	28;28;28	G;T;G	28;28;28	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	442	444	GAT	30;28;28	G;A;T	30;27;28	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	463	465	ACC	28;25;24	A;C,T;C	28;24,1;24	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	490	492	TTA	20;18;18	T;T;A	20;18;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	752	mdfA	1233	1233	96.67	mdfA.l15.c30.ctg.1	1852	30.7	0	.	p	.	0	G88fs	FSHIFT	262	262	G	550	550	G	24	G	24	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	616	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1833	25.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	305	305	G	21	G	20	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	616	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1833	25.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	362	364	CAG	15;15;15	C;A;G	15;15;15	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	616	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1833	25.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	512	514	ATC	11;11;13	A;T;C	11;11;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	616	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1833	25.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	560	562	ATG	15;15;15	A;T;G	15;15;14	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	616	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1833	25.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	653	655	ACC	18;19;19	A;C;C	18;19;19	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1892	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3567	39.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1996	1998	ACC	57;57;54	A;C;C	57;55;53	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1892	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3567	39.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2389	2391	CAA	32;32;32	C;A;A	32;32;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1892	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3567	39.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2557	2559	ATT	28;28;28	A;T;T	28;28;28	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1892	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3567	39.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2641	2643	GTT	23;24;24	G;T;T	23;23;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1892	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3567	39.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2749	2751	GAG	46;45;45	G;A;G	46;44;45	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1892	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3567	39.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2977	2979	ATG	44;44;44	A;T;G	44;43;43	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1892	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3567	39.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3112	3114	GAT	29;28;30	G;A;T,G	28;25;28,1	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1588	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3716	32.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	491	493	ATG	16;16;15	A;T;G	14;15;13	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1588	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3716	32.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	977	979	ATC	42;42;44	A;T;C	40;42;44	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1588	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3716	32.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3293	3295	CAC	13;13;13	C;A;C	13;10;12	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	938	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2131	33.3	0	.	p	.	0	D3E	NONSYN	7	9	GAT	379	381	GAA	21;20;20	G;A;A	21;20;20	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	938	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2131	33.3	0	.	p	.	0	T226A	NONSYN	676	678	ACG	1048	1050	GCG	28;32;32	G;C;G	28;32;32	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	938	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2131	33.3	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1390	1392	ATC	40;42;43	A;T;C	40;42;42	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	938	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2131	33.3	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1693	1695	TTT	51;51;51	T;T;T	51;50;50	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	974	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1918	38.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2352	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3800	46.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1169	1171	ACC	38;38;38	A;C;C	38;38;38	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2352	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3800	46.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2411	2413	GAC	31;33;34	G;A;C	31;33;34	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1080	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1694	38.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	749	751	ATC	55;54;56	A;T;C	54;54;56	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1080	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	695	22.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	178	180	GGA	20;20;19	G;G;A	20;20;19	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	654	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1737	28.3	0	.	p	.	0	G134C	NONSYN	400	402	GGT	643	645	TGT	35;35;35	T;G;T	35;35;34	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	654	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1737	28.3	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1213	1215	TTG	42;42;44	T;T;G	41;42;44	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	654	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1737	28.3	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1423	1425	ACG	5;5;5	A;C;G	4;5;5	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1000	mdtL	1176	1176	98.38	mdtL.l6.c4.ctg.1	1945	38.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	925	927	TCC	44;46;46	T;C;C	41;45;46	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	564	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1703	24.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	667	669	ATT	26;26;26	A;T;T	26;26;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	280	282	ATG	32;32;31	A;T;G	32;31;30	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	346	348	ATC	14;14;14	A;T;C	14;14;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	595	597	CGC	41;41;42	C;G;C	41;41;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	961	963	AGC	42;42;40	A;G;C	41;42;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1162	1164	GTG	54;53;53	G;T;G	52;52;52	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1225	1227	AAC	17;17;18	A;A,C;C	13;12,1;13	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1270	1272	GTC	36;36;36	G;T;C	36;35;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1300	1302	ATA	51;52;52	A;T;A	51;51;52	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1408	1410	TCT	38;37;38	T;C;T	35;35;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1795	1797	GCG	37;39;39	G;C;G	36;36;37	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1318	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2636	37.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2008	2010	ATC	31;31;31	A;T;C	31;31;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	482	482	T	41	T	39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	665	667	GCG	28;28;29	G;C;G	28;27;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	839	841	ACC	42;42;42	A;C;C	42;40;41	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	911	913	CGC	45;43;44	C;G;C	45;43;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1028	1030	GCT	35;36;36	G;C;T	35;36;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1112	1114	AAA	18;20;19	A;A;A	18;20;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1130	1132	CGA	21;21;21	C;G;A	21;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1295	1297	GCC	24;25;25	G;C;C	24;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1307	1309	GAT	27;27;30	G;A;T	27;26;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	778	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	2055	28.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1724	1726	GCT	23;23;23	G;C;T	23;22;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2318	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4081	42.8	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1617	1619	AAG	36;37;37	A,G;A;G	35,1;37;37	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2318	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4081	42.8	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2694	2696	CTG	38;38;37	C;T;G	38;38;37	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	358	mgrB	144	144	100.0	mgrB.l6.c30.ctg.1	809	33.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1774	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2597	51.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1189	1191	AAC	49;49;47	A;A;C	47;47;47	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1774	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2597	51.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1735	1737	ATA	74;74;78	A;T;A	73;74;78	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	984	murA_12	1260	1260	98.57	murA_12.l15.c17.ctg.1	1899	38.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1432	1434	GAT	50;49;49	G;A;T	50;49;49	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	984	murA_12	1260	1260	98.57	murA_12.l15.c17.ctg.1	1899	38.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1435	1437	CTG	49;48;48	C;T;G	49;47;48	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	471	473	TGT	51;51;52	T;G;T	51;51;52	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	741	743	ACC	53;53;52	A;C,T;C	50;52,1;51	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	951	953	GAC	40;39;41	G;A;C	39;38;41	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	1	SNP	p	R15C	0	.	.	43	45	CGC	435	437	CGC	57;56;54	C;G;C	56;56;53	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	1	SNP	p	S33R	0	.	.	97	99	AGC	489	491	AGC	57;56;56	A;G;C	57;56;56	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	1	SNP	p	G131D	0	.	.	391	393	GGC	783	785	GGC	42;42;43	G;G;C	42;42;43	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	1	SNP	p	R203L	0	.	.	607	609	CGT	999	1001	CGT	49;49;49	C;G;T	49;48;48	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	544	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1465	27.6	1	SNP	p	R203C	0	.	.	607	609	CGT	999	1001	CGT	49;49;49	C;G;T	49;48;48	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1240	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1753	53.4	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1236	1238	GAG	75;73;73	G;A;G	74;73;73	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1240	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1753	53.4	1	SNP	p	G141D	0	.	.	421	423	GGT	723	725	GGT	72;72;71	G;G;T	72;72;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1240	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1753	53.4	1	SNP	p	G141E	0	.	.	421	423	GGT	723	725	GGT	72;72;71	G;G;T	72;72;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1240	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1753	53.4	1	SNP	p	R154A	0	.	.	460	462	CGT	762	764	CGT	67;67;67	C;G;T	67;67;67	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1240	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1753	53.4	1	SNP	p	R154D	0	.	.	460	462	CGT	762	764	CGT	67;67;67	C;G;T	67;67;67	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1628	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	3012	40.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	2007	2009	TCG	41;41;41	T;C;G	40;41;41	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1628	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	3012	40.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2622	2624	AAC	40;40;40	A;A;C	40;40;40	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1628	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	3012	40.8	1	SNP	p	A85T	0	.	.	253	255	GCG	636	638	GCG	59;57;60	G;C;G	57;56;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1628	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	3012	40.8	1	SNP	p	D111H	0	.	.	331	333	GAT	714	716	GAT	30;33;33	G;A;T	28;32;32	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1628	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	3012	40.8	1	SNP	p	S129P	0	.	.	385	387	TCC	768	770	TCC	37;33;33	T;C;C	35;31;31	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1320	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2665	37.5	0	.	p	.	0	D476A	NONSYN	1426	1428	GAT	1803	1805	GCT	52;53;54	G;C;T	50;53;52	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1028	patA	1380	1380	99.86	patA.l6.c4.ctg.1	2150	36.0	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1459	1461	GAT	43;44;44	G;A;T	42;41;43	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	V146F	0	.	.	436	438	GTT	696	698	GTT	64;60;60	G;T;T	63;59;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1797	1799	CAG	72;72;74	C;A;G	72;69;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1797	1799	CAG	72;72;74	C;A;G	72;69;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1836	1838	CAC	44;45;45	C;A;C	43;43;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1845	1847	CGT	43;43;43	C;G;T	43;43;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1845	1847	CGT	43;43;43	C;G;T	43;43;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1851	1853	TCC	38;39;39	T;C;C	38;39;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1857	1859	CTC	37;37;37	C;T;C	37;36;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1947	1949	ACC	68;69;70	A;C;C	68;69;70	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1950	1952	CCT	69;70;69	C;C;T,C	69;70;67,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3028	rpoB	4029	4029	99.03	rpoB.l6.c17.ctg.1	4572	49.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2319	2321	CGT	67;65;64	C;G;T	67;65;62	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	.	n	.	0	A226G	SNP	226	226	A	421	421	G	480	G	476	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	A794G	0	.	.	794	794	A	989	989	A	340	A	331	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	A794T	0	.	.	794	794	A	989	989	A	340	A	331	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	G926A	0	.	.	926	926	G	1121	1121	G	314	G	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	G926T	0	.	.	926	926	G	1121	1121	G	314	G	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	G926C	0	.	.	926	926	G	1121	1121	G	314	G	313	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	1714	1714	A	271	A	268	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	1714	1714	A	271	A	268	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	1714	1714	A	271	A	268	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	G474A	.	474	474	G	669	669	G	390	G,A	255,131	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	C194T	.	194	194	C	389	389	C	501	C,T	386,110	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	G1002A	.	1002	1002	G	1197	1197	G	468	G,A	336,129	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	G1006C	.	1006	1006	G	1201	1201	G	480	G,C	340,132	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	A79G	.	79	79	A	274	274	A	501	A,G	355,137	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	C719T	.	719	719	C	914	914	C	380	C,T	261,115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	T273A	.	273	273	T	468	468	T	347	T,A	253,90	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	T1010C	.	1010	1010	T	1205	1205	T	474	T,C	328,140	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	T90C	.	90	90	T	285	285	T	479	T,C	344,131	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	C1038T	.	1038	1038	C	1233	1233	C	429	C,T	294,131	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	C183T	.	183	183	C	378	378	C	492	C,T	310,176	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	A250T	.	250	250	A	445	445	A	407	A,T	306,97	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	10120	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1750	393.9	0	HET	.	.	.	A253T,C	.	253	253	A	448	448	A	409	A,T,C	304,96,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	468	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1291	27.3	1	SNP	p	R20H	0	.	.	58	60	CGC	440	442	CGC	70;70;71	C;G;C	68;70;70	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	468	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1291	27.3	1	SNP	p	G121D	0	.	.	361	363	GGT	743	745	GGT	46;47;44	G;G;T	46;47;43	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	332	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	922	26.8	1	SNP	p	A12S	0	.	.	34	36	GCA	318	320	GCA	57;58;58	G;C;A	57;58;58	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	16	10	APH_3____Ib+	804	157	100.0	APH_3____Ib+.l15.c4.ctg.1	157	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1338	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	2337	43.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
